cm-1 chronic constipation: an unresolved problem for many patients charlene prather, md division of...
TRANSCRIPT
CM-1CM-1
Chronic Constipation: An Unresolved Problem for
Many Patients
Chronic Constipation: An Unresolved Problem for
Many Patients
Charlene Prather, MD
Division of Gastroenterology and Hepatology
Saint Louis University School of Medicine
Charlene Prather, MD
Division of Gastroenterology and Hepatology
Saint Louis University School of Medicine
CM-2CM-2
Presentation ObjectivesPresentation Objectives
Definition of chronic constipation
Epidemiology and resource utilization
Review of available therapies and limitations
Unmet medical need
Definition of chronic constipation
Epidemiology and resource utilization
Review of available therapies and limitations
Unmet medical need
C
CM-3CM-3
Definition: Causes of Chronic ConstipationDefinition: Causes of Chronic Constipation
Secondary– Drug induced – Metabolic factors– Comorbid conditions
Primary– Impaired colonic transit/motility
• Altered neuroenteric function and reflexes• Failure of muscular apparatus
– Ineffective defecation (functional outlet obstruction)• Pelvic dyssynergia and anismus
– Normal transit constipation
C
CM-4CM-4
Constipation Is a Constellation of SymptomsConstipation Is a Constellation of Symptoms
Most commonly reported symptoms
– Hard, lumpy stools
– Increased straining
– Infrequent bowel movements
– Sensation of incomplete evacuation
– Bloating/fullness Chronic constipation
– More persistent than intermittent or episodic
– Several months duration
Most commonly reported symptoms
– Hard, lumpy stools
– Increased straining
– Infrequent bowel movements
– Sensation of incomplete evacuation
– Bloating/fullness Chronic constipation
– More persistent than intermittent or episodic
– Several months duration
C
CM-5CM-5
52
44
3432
20 19
11
0
10
20
30
40
50
60
Straining Hard stools
Want to but can't
Infrequentstools
Abdominaldiscomfort
Haven'tfinished
Excesstoilet time
Pa
tie
nts
, %
Sandler RS, et al. Dig Dis Sci. 1987;32:841-845.
n = 1128
Constipation Is More Than JustInfrequent Passage of StoolConstipation Is More Than JustInfrequent Passage of Stool
53
Constipation symptoms reported most often
CM-6CM-6Reduced Stool Frequency Is Not the Most Commonly Reported Symptom in Constipation
Reduced Stool Frequency Is Not the Most Commonly Reported Symptom in Constipation
13
26
32
36
65
83
0 20 40 60 80 100
< 3 BM/wk
Abdominal bloating ≥ 6 days
Press on abdomen
Abdominal discomfort
Unsuccessful BM
Incomplete BM
Patients, %
28
36
37
39
54
72
81
0 20 40 60 80 100
Press on anus
< 3 BM/wk
Abdominal bloating
Stool cannot pass
Incomplete evacuation
Hard stool
Straining
Patients, %
EPOC = Epidemiology of constipation; BM = Bowel movement.1. Stewart WF, et al. Am J Gastroenterol. 1999;94:3530-3540.2. Paré P, et al. Am J Gastroenterol. 2001;96:3130-3137.
Stewart (EPOC) 19991 Paré 20012
n = 1476 n = 1149
Constipation symptoms reported most often
C
CM-7CM-7
Rome II Defines Functional Constipation Based on Multiple SymptomsRome II Defines Functional Constipation Based on Multiple Symptoms
Rome II diagnostic criteria for functional constipation At least 12 wk, which need not be consecutive, over the past
12 months of 2 or more of
– Straining*
– Lumpy or hard stools*
– Sensation of incomplete evacuation*
– Sensation of anorectal obstruction/blockage*
– Manual maneuvers to facilitate defecation*
– < 3 defecations/wk Loose stools not present Insufficient criteria for IBS
Rome II diagnostic criteria for functional constipation At least 12 wk, which need not be consecutive, over the past
12 months of 2 or more of
– Straining*
– Lumpy or hard stools*
– Sensation of incomplete evacuation*
– Sensation of anorectal obstruction/blockage*
– Manual maneuvers to facilitate defecation*
– < 3 defecations/wk Loose stools not present Insufficient criteria for IBS
* > 1/4 of defecations.Drossman DA, et al. In: Rome II: The Functional Gastrointestinal Disorders. 2000:382-391.
C
CM-8CM-8
Prevalence in the General PopulationPrevalence in the General Population
1. Stewart WF, et al. Am J Gastroenterol. 1999;94:3530-3540.2. Drossman DA, et al. Dig Dis Sci. 1993;38:1569-1580.3. Harris Interactive Study, Wave 2. Data on file. 4. Paré P, et al. Am J Gastroenterol. 2001;96:3130-3137.
53
Population n Criteria
Prevalence, n (%)
US1 10,018 Rome I 461 (4.6)
US2 5430 Rome I 195 (3.6)
US3 15,183 Rome II
2429 (16)
Canada4 1149 Rome II
171 (14.9)
CM-9CM-9
Approximately 25% of Sufferers Seek CareApproximately 25% of Sufferers Seek Care
1. Stewart WF, et al. Am J Gastroenterol. 1999;94:3530-3540.2. Drossman DA, et al. Dig Dis Sci. 1993;38:1569-1580.3. Harris Interactive Study, Wave 2. Data on file. 4. Paré P, et al. Am J Gastroenterol. 2001;96:3130-3137.
53
Population n Criteria
Prevalence, n (%)
Sought care,%
US1 10,018 Rome I 461 (4.6) NA
US2 5430 Rome I 195 (3.6) 22
US3 15,183 Rome II
2429 (16) 24
Canada4 1149 Rome II
171 (14.9) 26
CM-10CM-10
Constipation Affects All Age GroupsConstipation Affects All Age Groups
53
Canadian population.Paré P, et al. Am J Gastroenterol. 2001;96:3130-3137.
0
5
10
15
20
25
18 - 34 35 - 49 50 - 64 > 64
Age group, yr
Co
nst
ipat
ed,
%
Rome I
Rome II
N = 1149
n = 378 n = 367 n = 217 n = 187
CM-11CM-11
EpidemiologyEpidemiology
Chronic constipation is common
Slightly more common in women
– F/M ratio = range 1.3 to 2.5
Affects all age groups
Chronic constipation is common
Slightly more common in women
– F/M ratio = range 1.3 to 2.5
Affects all age groups
Stewart WF, et al. Am J Gastroenterol. 1999;94:3530-3540.Paré P, et al. Am J Gastroenterol. 2001;96:3130-3137.Sandler RS, et al. Dig Dis Sci. 1987;32:841-845.
C
CM-12CM-12
Profile of a Typical Chronic Constipation Patient in My PracticeProfile of a Typical Chronic Constipation Patient in My Practice
Generally female
Symptomatic for > 10 yr
Majority have tried lifestyle changes, fiber, and OTC laxatives prior to seeking care
Manages condition with multiple therapies
Most often referred by a primary care physician
Copes with condition, but is not completely satisfied
Generally female
Symptomatic for > 10 yr
Majority have tried lifestyle changes, fiber, and OTC laxatives prior to seeking care
Manages condition with multiple therapies
Most often referred by a primary care physician
Copes with condition, but is not completely satisfied
C
CM-13CM-13
Constipation Can Have a Negative Impact on Quality of LifeConstipation Can Have a Negative Impact on Quality of Life
In Olmstead County, Minnesota, people with CC reported significant impairment in QoL on SF-36 scale (n = 126)1
In Canada, people with self-reported or Rome II constipation had significantly worse SF-36 scores than the normal population (n = 472)2
In Australia, people with constipation had significantly worse SF-12 scores on both mental and physical scales (n = 227)3
In Olmstead County, Minnesota, people with CC reported significant impairment in QoL on SF-36 scale (n = 126)1
In Canada, people with self-reported or Rome II constipation had significantly worse SF-36 scores than the normal population (n = 472)2
In Australia, people with constipation had significantly worse SF-12 scores on both mental and physical scales (n = 227)3
1. O’Keefe EA, et al. J Gerontol A Biol Sci Med Sci. 1995;50:M184-M189.2. Irvine EJ, et al. Am J Gastroenterol. 2002;97:1986-1993. 3. Koloski NA, et al. Am J Gastroenterol. 2000;95:67-71.
C
CM-14CM-14
Constipation Significantly Impacts Healthcare UtilizationConstipation Significantly Impacts Healthcare Utilization
5.7 million constipation-related outpatient visits annually1,2
– 4.1 million physician office-based visits
– 991,000 emergency room visits
– 587,000 hospital outpatient visits
$2752/patient for tertiary care evaluation3
5.7 million constipation-related outpatient visits annually1,2
– 4.1 million physician office-based visits
– 991,000 emergency room visits
– 587,000 hospital outpatient visits
$2752/patient for tertiary care evaluation3
1. National Ambulatory Medical Care Survey, 2001. www.cdc.gov2. National Hospital Ambulatory Care Survey, 2001. www.cdc.gov3. Rantis PC Jr, et al. Dis Colon Rectum. 1997;40:280-286.
C
CM-15CM-15
Goal of Therapy in Chronic ConstipationGoal of Therapy in Chronic Constipation
The goal of therapy is to improve GI function in order to provide relief of key symptoms:
– Straining
– Hard/lumpy stools
– Feeling of incomplete evacuation
– Infrequent bowel movements
– Bloating/fullness
The goal of therapy is to improve GI function in order to provide relief of key symptoms:
– Straining
– Hard/lumpy stools
– Feeling of incomplete evacuation
– Infrequent bowel movements
– Bloating/fullness
53
CM-16CM-16
Medications Commonly Used for ConstipationMedications Commonly Used for Constipation
Fiber
Laxatives
– Osmotic laxatives
– Stimulant laxatives
Enemas or suppositories
Miscellaneous
Fiber
Laxatives
– Osmotic laxatives
– Stimulant laxatives
Enemas or suppositories
Miscellaneous
53
Adapted from Lembo A, et al. N Engl J Med. 2003;349:1360-1368.
CM-17CM-17
Efficacy of Current Treatments for Chronic Constipation Efficacy of Current Treatments for Chronic Constipation
Variable treatment responses
For the constellation of constipation symptoms, efficacy not evaluated or demonstrated with most agents
Most agents indicated for ≤ 2 wk of treatment
Variable treatment responses
For the constellation of constipation symptoms, efficacy not evaluated or demonstrated with most agents
Most agents indicated for ≤ 2 wk of treatment
53
Petticrew M, et al. Qual Health Care. 2001;10:268-273. Jones MP, et al. Dig Dis Sci. 2002;47:2222-2230. Rao SS. Gastroenterol Clin North Am. 2003;32:659-683.
CM-18CM-18
Limitations of Current Treatmentsfor ConstipationLimitations of Current Treatmentsfor Constipation Worsening of some constipation symptoms
– Bloating and gas– Cramping, abdominal pain/colic
Development of complications – Diarrhea, hypovolemia – Metabolic disturbances
Other adverse effects– Interference with concomitant drug absorption– Structural changes in gut mucosa– Abuse potential (dependency)
Diminished therapeutic effect over time
Worsening of some constipation symptoms– Bloating and gas– Cramping, abdominal pain/colic
Development of complications – Diarrhea, hypovolemia – Metabolic disturbances
Other adverse effects– Interference with concomitant drug absorption– Structural changes in gut mucosa– Abuse potential (dependency)
Diminished therapeutic effect over time
C
Xing JH, et al. Dis Colon Rectum. 2001 Aug;44:1201-1209. Garcia MC, et al. Tenn Med. 2002 Aug;95:334-336. Chaussade S, et al. Aliment Pharmacol Ther. 2003 Jan;17:165-172. Riley SA, et al. Br J Clin Pharmacol. 1992 Jul;34:40-46. Gattuso JM, et al. Drug Saf. 1994 Jan;10:47-65. Wald A. J Clin Gastroenterol. 2003;36:386-89. Duncan A, et al. Eur J Gastroenterol Hepatol. 2001;13:599-601.
CM-19CM-19
Physicians Believe Patient Satisfaction With Current Therapies Is LowPhysicians Believe Patient Satisfaction With Current Therapies Is Low
YesYes18%18%
Are your patients completely satisfied?
NoNo82%82%
Schiller LR, et al. Am Coll Gastroenterol. 2004, abstract submitted.
C
n = 311
• 60% of physicians agreed that they do not have adequate products
• 90% of physicians wanted better treatment options
• Physicians cited “frustration with current treatments” one of the top 3 reasons patients state for seeking care
Reasons for dissatisfaction*
Efficacy 93%Safety/side effects 57%Other (ie, taste, compliance) 27%
*Not mutually exclusive.
CM-20CM-20
Many Constipation Patients Are Not Satisfied With Available TreatmentsMany Constipation Patients Are Not Satisfied With Available Treatments
Reasons for dissatisfaction* 1
Efficacy 82%Safety/side effects 16%Other (ie, taste, compliance) 17%
C
1. Schiller LR, et al. Am Coll of Gastroenterol. 2004, abstract submitted.2. Irvine EJ, et al. Am J Gastroenterol. 2002;97:1986-1993. 3. Ferrazzi S, et al. Can J Gastroenterol. 2002;16:159-164.
*Not mutually exclusive.
YesYes53%53%
Are you completelysatisfied? 1
NoNo47%47%
n = 557
CM-21CM-21
Chronic Constipation:A Condition in Need of a Better ApproachChronic Constipation:A Condition in Need of a Better Approach
Characterized by a constellation of symptoms
High resource utilization and significant negative impact on patients’ lives
Current pharmacologic agents have limitations Many patients are not satisfied with available
therapies Better treatment options are needed
Characterized by a constellation of symptoms
High resource utilization and significant negative impact on patients’ lives
Current pharmacologic agents have limitations Many patients are not satisfied with available
therapies Better treatment options are needed
C